Portage Biotech Announces Letter of Intent with Immunova for an O... ... Health, San Antonio. Key Highlights from the Presentation: Nine of 20 ...
News
- Plus Therapeutics Reports Promising 88% Response Rate in Phase 1 Cancer Treatment Trial
- Semi-Dry Dot-Blot Kit Detects Macrometastases in Patients With Breast Cancer
... San Antonio Breast Cancer Symposium. The kit uses the SDB method and an ... Nagasaki University Graduate School of Biomedical Sciences. Photo ...
- Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors - Quantisnow
... Health Science Center at San Antonio. In this open-label, single-arm study (NCT04187898), conducte. 12/13/24 8:00:00 AM ET. $ASRT. Biotechnology ...
- Join bioAffinity Technologies' Exclusive Live Investor Webinar and Q&A Session on ... - Stock Titan
SAN ANTONIO --(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive ...
- Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim D - GuruFocus
... Biotechnology PSTV. Plus Therapeutics Presents Positive ReSPECT-LM ... Health, San Antonio. Key Highlights from the Presentation: Nine of 20 ...